Clinical Trial Update: Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age [Phase 1]

View source ↗

Summary

This update covers a pediatric pharmacokinetic study of rezafungin in children from birth to under 18 years with invasive fungal infections, which has been term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infections

Drugs mentioned

• Rezafungin (rezafungin)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Invasive Fungal Infections | Phase 1 | Status: TERMINATED